Atyr Pharma Inc (ATYR)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Sanjay S. Shukla |
| Employees: | 53 |
| Web site: | atyrpharma.com |
|
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
8587318389
| |
| Date | Ratio |
|---|---|
| 2019-07-01 | 1:14 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trials for treatment of other interstitial lung diseases (ILDs) The company was incorporated in 2005 and is headquartered in San Diego, California.
Please log in first to see chart